DRP Journal

Capricor Therapeutics (NASDAQ:CAPR) Stock Bounces Back After The Fall: What Next?

The biotech firm Capricor Therapeutics (NASDAQ:CAPR) was on the radars of many investors yesterday and the company’s stock ended the